ReviewCurrent genetics2025
Epigenetic regulation of pathogenicity in fungi.
Review in Current genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenetic regulation of metabolism in Saccharomyces cerevisiae: mechanisms, metabolic crosstalk, and engineering applications.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Histone modifications regulate vital pathogenic features necessary for opportunistic fungi to cause disease. More specifically, histone modification via acetylation and methylation are two major ways that fungi regulate their growth, replication, and ability to respond to stress. This is critically important, as these genes can be potential targets for drug therapies in these difficult-to-treat pathogens. For fungi to rapidly respond to changes in their environment, they must quickly and efficiently adapt to their surroundings. Epigenetic control mechanisms, such as histone modification, allow the fungus to adapt to conditions without altering its DNA. As in other eukaryotes, fungal DNA is tightly packaged into an organized complex known as chromatin and wound around histone proteins. As these histones are modified by methylation or acetylation, specific sections of DNA can become accessible to transcriptional machinery. These histone modifications may interact with various other proteins to accomplish their functions, as well. In this way, histone modifications allow microorganisms to rapidly modify gene expression and respond to their environment. In this review, histone modifications via methylation, demethylation, acetylation, and deacetylation for select model and pathogenic fungal species are summarized concerning how they affect growth, stress response, and gene expression, as applicable. Additionally, the roles of epigenetic regulation in virulence factor expression, toxin formation, and disease are explored. Lastly, current knowledge pertaining to novel drugs and drug targets related to histone acetylation, deacetylation, and demethylation is discussed. Understanding the diverse roles of epigenetic regulation in fungal disease is a crucial first step in exploiting this critical linchpin for novel antifungal treatments of these important human pathogens.
Indexed as
Identifiers
41123694What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.